OPTIC: Improving access to opioid treatment and community overdose response
Center to Advance Research Excellence (OPTIC)
['FUNDING_OTHER'] · RAND CORPORATION · NIH-11125933
This center works to find better policies and programs that help people with opioid use disorder get effective treatment and avoid overdoses.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | RAND CORPORATION (nih funded) |
| Locations | 1 site (SANTA MONICA, UNITED STATES) |
| Trial ID | NIH-11125933 on ClinicalTrials.gov |
What this research studies
If you or your community are affected by opioid problems, this center uses state and national data, community surveys, and policy analysis to learn what helps people get medications like buprenorphine and access naloxone. Researchers combine health records, prescription and overdose data, and local information to understand how policies affect different places and groups. They also conduct community-focused studies and build data tools that policymakers and local leaders can use. The goal is to guide changes that reduce deaths and expand proven treatments across diverse communities.
Who could benefit from this research
Good fit: People with opioid use disorder, family members, community organizations, or local health officials in affected U.S. communities are the most likely participants or data contributors.
Not a fit: People without opioid exposure or those living outside the U.S. or in communities not included in the center's data may not see direct benefits.
Why it matters
Potential benefit: Could lead to policies and programs that increase access to life-saving treatments and reduce fatal overdoses.
How similar studies have performed: Previous policy and community studies have improved medication access and naloxone distribution, and this center builds on those findings with new data tools and methods.
Where this research is happening
SANTA MONICA, UNITED STATES
- RAND CORPORATION — SANTA MONICA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: STEIN, BRADLEY D — RAND CORPORATION
- Study coordinator: STEIN, BRADLEY D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.